Internal Medicine, Allergy & Immunology · Daleville, VA
NPI
1003896770
Since 2006
Specialty
Internal Medicine, Allergy & Immunology
Code 207RA0201X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
46 Wesley Rd
Daleville, VA, 24083
Phone (540) 591-9447
Groups this clinician bills Medicare through
Medicare paid, 2024
$98K
2,788 services
Medicare patients, 2024
225
Average age 71
Drug cost, 2024
$5.0M
2,226 prescriptions
Company payments, 2024
$124
From 1 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aneysa C Sane was code 96160 (e&m - miscellaneous), 266 times for 167 patients. In total Aneysa C Sane billed 2,788 services in 52 codes, and Medicare paid $98K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2025-11-10.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 96160 E&M - Miscellaneous | Office | 266 | 167 | $2.15 | $573 |
| 95117 Treatment - Miscellaneous | Office | 264 | 12 | $8.38 | $2,212 |
| 99214 Office E&M - Established | Office | 242 | 148 | $89.36 | $22K |
| 36415 Venipuncture Blood Collection | Office | 123 | 91 | $8.58 | $1,056 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 114 | 86 | $12.62 | $1,438 |
| 94010 Pulmonary Function Testing | Office | 76 | 71 | $19.09 | $1,451 |
| 99215 Office E&M - Established | Office | 48 | 35 | $135.90 | $6,523 |
| 99204 Office E&M - New | Office | 31 | 31 | $98.07 | $3,040 |
| 99205 Office E&M - New | Office | 30 | 30 | $163.97 | $4,919 |
By year: 2022 $90K for 2,668 services; 2023 $69K for 2,426 services; 2024 $98K for 2,788 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 123 | 91 | $8.58 | $1,056 |
Medicare prescription drug claims, 2024
In 2024, the drug Aneysa C Sane prescribed most often to Medicare patients was Montelukast Sodium, with 265 prescriptions and refills. In total Aneysa C Sane wrote 2,226 Medicare prescriptions that cost $5.0M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Montelukast Sodium Generic | 265 | 778 | 90 | $2,835 |
| Azelastine Hcl Generic | 185 | 391 | 64 | $9,582 |
| Albuterol Sulfate Hfa Albuterol Sulfate | 151 | 214 | 47 | $5,048 |
| Fluticasone Propionate Generic | 110 | 285 | 45 | $2,038 |
| Dupixent Pen Dupilumab | 86 | 92 | 15 | $341K |
| Famotidine Generic | 79 | 177 | 22 | $1,848 |
| Ipratropium Bromide Generic | 70 | 120 | 27 | $2,674 |
| Prednisone Generic | 65 | 110 | 22 | $344 |
| Losartan Potassium Generic | 61 | 157 | 21 | $463 |
| Epinephrine Generic | 59 | 61 | 50 | $9,463 |
| Dupixent Syringe Dupilumab | 50 | 50 | Under 11 | $190K |
| Spiriva Respimat Tiotropium Bromide | 42 | 91 | 14 | $37K |
| Mounjaro Tirzepatide | 41 | 50 | Under 11 | $53K |
| Advair Hfa Fluticasone Propion/Salmeterol | 40 | 80 | 11 | $30K |
| Trelegy Ellipta Fluticasone/Umeclidin/Vilanter | 37 | 49 | Under 11 | $32K |
Brand drugs: 833 claims; generic drugs: 1,393 claims.
Money and other things of value reported by the companies
In 2024, drug and medical device companies paid Aneysa C Sane $124 ($124 in general payments such as food, travel and fees) from 1 company. The largest payer was Kiniksa Pharmaceuticals International, plc with $124.
| Company | Payments | Amount |
|---|---|---|
| Kiniksa Pharmaceuticals International, plc KNSA | 1 | $124 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.